首页> 外国专利> v3 Integin v3-targeted probe for diagnosing retinochoroidal neovascular disease and method for manufacturing the same

v3 Integin v3-targeted probe for diagnosing retinochoroidal neovascular disease and method for manufacturing the same

机译:V3整体V3靶向探针,用于诊断视网膜体新生血管疾病及其制造方法

摘要

Provided are an integrin-targeting probe that can be usefully used in the diagnosis or treatment of retinal choroidal neovascularization or age-related macular degeneration by predicting the occurrence and recurrence of retinal choroidal neovascularization before the structural change of retinal choroidal neovascularization, and a method for preparing the same. This integrin-targeting probe is an integrin α v β 3 targeting probe for diagnosing retinal choroidal neovascular disease, and consists of a fluorescent substance-labeled cyclic RGD peptide completed by conjugating an NH 2 -cyclic RGD peptide precursor to a fluorescent substance. can
机译:提供一种整联蛋白靶向探针,可有效地用于通过预测视网膜脉络膜新生血管形成前视网膜脉络膜新生血管的发生和复发,以及一种方法 准备相同。 该整联素靶向探针是一种靶向探针的整合蛋白αVβ3,用于诊断视网膜脉络膜新生血管疾病,并由通过将NH 2 - 环RGD肽前体与荧光物质缀合而完成的荧光物质标记的环状RGD肽组成。 能够

著录项

  • 公开/公告号KR102307767B1

    专利类型

  • 公开/公告日2021-10-01

    原文格式PDF

  • 申请/专利权人 서울대학교병원;

    申请/专利号KR20190027284

  • 发明设计人 이병철;정재호;우세준;안성준;

    申请日2019-03-11

  • 分类号G01N33/68;A61K49;G01N33/58;

  • 国家 KR

  • 入库时间 2022-08-24 21:25:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号